Results 191 to 200 of about 17,901 (223)
Some of the next articles are maybe not open access.

Pharmacotherapy of intermittent claudication

Expert Opinion on Pharmacotherapy, 2001
Intermittent claudication (IC) is leg muscle pain, cramping and fatigue brought on by exercise and is the primary symptom of peripheral arterial disease. The goals of pharmacotherapy for IC are to increase the walking capacity/quality of life and to decrease rates of amputation.
openaire   +4 more sources

Management of intermittent claudication

Cardiology Clinics, 2002
Medical management of PAD is a considerable challenge. Although patients typically present with IC, there is a substantial pool of subclinical PAD patients. PAD, whether symptomatic or not, confers a marked cardiovascular risk; with affected patients dying of heart attack or stroke, identification of index patients and aggressive medical treatment can ...
Robert D, Brook   +3 more
openaire   +2 more sources

Pentoxifylline for intermittent claudication

2005
Intermittent claudication (IC) is a symptom of peripheral arterial occlusive disease (PAD). It is associated with high morbidity and mortality. Pentoxifylline is one of many drugs used to treat IC. Pentoxifylline decreases blood viscosity, improves erythrocyte flexibility, and increases microcirculatory flow and tissue oxygen concentration.Many studies
Kareem, Salhiyyah   +4 more
openaire   +2 more sources

Intermittent Claudication

Archives of Surgery, 1974
A study was made of 162 persons with intermittent claudication who were observed for an average of 8.3 years. These were all the cases that evolved from a population cohort during 18 years of follow-up. They were essentially untreated until rest pain and tissue loss began. Only four progressed to major amputations and three to toe loss.
C N, Peabody, W B, Kannel, P M, McNamara
openaire   +2 more sources

Intermittent claudication in athletes

The Journal of Sports Medicine, 1975
All reported cases have occurred in the anterior tibial or rarely peroneal compartments. Case I and V in this series follow this same pattern. Case II and III are unusual in that they are the first recorded cases of this syndrome occuring in the calf of a leg.
openaire   +2 more sources

Pentoxifylline and Intermittent Claudication

Annals of Internal Medicine, 1985
Excerpt The Food and Drug Administration has recently approved the use of pentoxifylline, a methylxanthine with vasoactive properties (1), for the symptomatic treatment of intermittent claudication...
openaire   +2 more sources

Prostanoids for intermittent claudication

2003
Peripheral arterial occlusive disease (PAOD) is a common cause of morbidity in the general population. While numerous studies have established the efficacy of prostanoids in PAOD stages III and IV the question of the role of prostanoids as an alternative or additive treatment in patients suffering from claudicatio intermittens (PAOD II) has not yet ...
M, Reiter   +3 more
openaire   +2 more sources

Intermittent Claudication

Drugs, 1987
The mainstay of treatment for claudication is reversal of risk factors, especially smoking, and the use of antiplatelet drugs and possibly pentoxifylline. A major factor in the long term management is atherosclerotic involvement in other parts of the circulation resulting in a shortened life span. Treatment should be directed at the disease in general,
openaire   +2 more sources

Intermittent Claudication — Be Conservative

New England Journal of Medicine, 1991
Severe peripheral vascular disease is a common disorder that frequently creates substantial morbidity in our aging population.
openaire   +2 more sources

Home - About - Disclaimer - Privacy